ATE382359T1 - Nahrungsmittelzusammensetzung und verfahren zu ihrer verwendung - Google Patents

Nahrungsmittelzusammensetzung und verfahren zu ihrer verwendung

Info

Publication number
ATE382359T1
ATE382359T1 AT99915377T AT99915377T ATE382359T1 AT E382359 T1 ATE382359 T1 AT E382359T1 AT 99915377 T AT99915377 T AT 99915377T AT 99915377 T AT99915377 T AT 99915377T AT E382359 T1 ATE382359 T1 AT E382359T1
Authority
AT
Austria
Prior art keywords
colostrum
food composition
work capacity
physical work
composition
Prior art date
Application number
AT99915377T
Other languages
English (en)
Inventor
Peter Whyte
Original Assignee
Numico Res Australia Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3807525&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE382359(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Numico Res Australia Pty Ltd filed Critical Numico Res Australia Pty Ltd
Application granted granted Critical
Publication of ATE382359T1 publication Critical patent/ATE382359T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/60Feeding-stuffs specially adapted for particular animals for weanlings
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/14Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
    • A23C9/142Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration
    • A23C9/1422Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration by ultrafiltration, microfiltration or diafiltration of milk, e.g. for separating protein and lactose; Treatment of the UF permeate
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/20Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • A23C9/206Colostrum; Human milk
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/30Feeding-stuffs specially adapted for particular animals for swines
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/18Peptides; Protein hydrolysates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/19Dairy proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20Milk; Whey; Colostrum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/30Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nutrition Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Immunology (AREA)
  • Animal Husbandry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Water Supply & Treatment (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Obesity (AREA)
  • Virology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT99915377T 1998-04-30 1999-04-30 Nahrungsmittelzusammensetzung und verfahren zu ihrer verwendung ATE382359T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPP3271A AUPP327198A0 (en) 1998-04-30 1998-04-30 A food composition and method of using same

Publications (1)

Publication Number Publication Date
ATE382359T1 true ATE382359T1 (de) 2008-01-15

Family

ID=3807525

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99915377T ATE382359T1 (de) 1998-04-30 1999-04-30 Nahrungsmittelzusammensetzung und verfahren zu ihrer verwendung

Country Status (14)

Country Link
US (1) US20120283185A1 (de)
EP (2) EP1889547A2 (de)
JP (1) JP4291513B2 (de)
CN (1) CN100350917C (de)
AT (1) ATE382359T1 (de)
AU (1) AUPP327198A0 (de)
BR (1) BR9910044A (de)
CA (1) CA2331071C (de)
DE (1) DE69937882T2 (de)
ES (1) ES2300140T3 (de)
HK (1) HK1033094A1 (de)
NZ (1) NZ338023A (de)
PL (1) PL343831A1 (de)
WO (1) WO1999056758A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6521591B1 (en) * 2000-02-10 2003-02-18 N.V. Nutricia Pharmaceutical composition for muscular anabolism
KR20040106298A (ko) * 2002-03-21 2004-12-17 아나디스 리미티드 불안정한 생활성 물질 및 포유동물 초유를 포함한 조성물,제조 및 치료 방법
PL1638416T3 (pl) * 2003-06-23 2013-09-30 Nestec Sa Zastosowanie żywnościowego preparatu do optymalizowania działania bariery jelitowej
WO2005029979A1 (de) * 2003-09-19 2005-04-07 Bomba Energia Getränkevertriebs GmbH Mineral-, vitamin- und aminosäurehaltiges getränk
EP1675480B1 (de) 2003-10-16 2018-06-13 Nestec S.A. Nahrhafte zusammensetzung gegen die nebenwirkungen von chemotherapie oder strahlentherapie
EP1723951A1 (de) * 2005-04-21 2006-11-22 N.V. Nutricia Nahrungsergänzungspräparat mit Oligosacchariden für eine Kategorie von HIV Patienten
US8252341B2 (en) 2004-09-14 2012-08-28 Paul Brazeau Isolation of growth and differentiating factors from colostrum
WO2006029494A1 (en) * 2004-09-14 2006-03-23 Nexcell Biosciences Inc. Extraction of growth and differentiating factors from colostrum
BRPI0518552A2 (pt) 2004-12-24 2008-12-30 Dolphst Pty Ltd formulaÇço para o bem estar em seres humanos e mÉtodo para aumentar o bem-estar de um paciente humano
WO2007028211A1 (en) * 2005-09-09 2007-03-15 Murray Goulburn Co-Operative Co Limited Composition of whey growth factor extract for reducing muscle inflammation
WO2007028210A1 (en) * 2005-09-09 2007-03-15 Murray Goulburn Co-Operative Co Limited Milk derived composition and use to enhance muscle mass or muscle strength
ES2436890T3 (es) 2010-01-29 2014-01-07 Abbott Laboratories Líquidos nutricionales envasados asépticamente que comprenden HMB
EP2528459B1 (de) 2010-01-29 2014-06-11 Abbott Laboratories Nährstoffemulsionen mit calcium-hmb
US9693577B2 (en) 2010-01-29 2017-07-04 Abbott Laboratories Method of preparing a nutritional powder comprising spray dried HMB
JP2011201842A (ja) * 2010-03-26 2011-10-13 Kobayashi Pharmaceutical Co Ltd 腸由来細胞の増殖促進剤
TWI526161B (zh) 2010-06-10 2016-03-21 亞培公司 包含鈣hmb及可溶性蛋白質之實質上透明營養液
MX359453B (es) * 2011-03-18 2018-09-28 Nestec Sa Composiciones y métodos útiles para aliviar los padecimientos relacionados con la edad.
CN104379153A (zh) 2012-06-07 2015-02-25 哥本哈根大学 作为早产儿的最低限度肠道营养的牛初乳
CN103478707B (zh) * 2013-08-23 2015-04-08 楼秀余 胰岛素样生长因子-ⅰ缓释片及其制备方法
WO2015095650A1 (en) 2013-12-19 2015-06-25 Puretein Bioscience Llc. Methods for treating an animal
MX2017007905A (es) * 2014-12-16 2017-09-05 Puretein Bioscience Llc Metodos para aumentar el factor de crecimiento insulinico 1 (igf-1) en suero en un animal.
WO2016199798A1 (ja) * 2015-06-10 2016-12-15 味の素株式会社 運動誘発性の消化管障害の改善剤
WO2017191638A1 (en) * 2016-05-06 2017-11-09 Hadasit Medical Research Services & Development Limited Hyperimmune colostrum in the modulation and treatment of conditions associated with the mammailan microbiome
EP4132290A1 (de) * 2020-04-07 2023-02-15 Puretein Bioscience, LLC Zusätze und zusammensetzungen mit aminosäuren und igf-1 und verfahren zur verwendung
CN117750889A (zh) * 2021-02-26 2024-03-22 潘思瑞公司 稳定的初乳组合物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4051235A (en) * 1976-04-22 1977-09-27 Plymate Robert R Method of preparing bovine colostrum for use in treating livestock
FR2469875B1 (fr) * 1979-08-03 1987-05-29 Oraa Extrait sec de colostrum et procede pour sa fabrication
NZ239466A (en) 1990-08-17 1993-12-23 Us Agriculture Desalted colostrum: spray dried product from retentate of
JPH06510065A (ja) * 1992-06-08 1994-11-10 カイロン コーポレーション 成長因子igf−iおよび/またはigf−iiの用法
FI97269B (fi) * 1993-10-12 1996-08-15 Viable Bioproducts Ltd Menetelmä ravintojuoman valmistamiseksi
AU668033B2 (en) 1994-05-16 1996-04-18 N.V. Nutricia Colostrum preparation and storage
AUPN642795A0 (en) * 1995-11-08 1995-11-30 Northfield Laboratories Pty Ltd Dairy compositions and methods of preparing same
AU709952B2 (en) * 1995-11-08 1999-09-09 N.V. Nutricia Liquid colostrum for dairy products
DE29623125U1 (de) * 1996-05-17 1997-11-06 Adler Charlotte Kolostralmilchprodukte
ATE232738T1 (de) * 1996-07-02 2003-03-15 Pharmaproducts Uk Ltd Kolostrum enthaltende pharmazeutische zusammensetzungen und deren verwendung
GB9619634D0 (en) * 1996-09-20 1996-11-06 Scient Hospital Suppl Int Ltd Prevention of gastrointestinal damage
GB9619660D0 (en) * 1996-09-20 1996-11-06 Scient Hospital Suppl Int Ltd Prevention of gastrointestinal damage
IT1291340B1 (it) * 1997-05-09 1999-01-07 Vander Way Limited Formulazioni farmaceutiche contenenti colostro e uso del colostro per il trattamento di affezioni del cavo orale
US5846569A (en) * 1997-06-20 1998-12-08 Creative Labs, Inc. Colostrum supplement

Also Published As

Publication number Publication date
EP1073444A1 (de) 2001-02-07
BR9910044A (pt) 2001-11-06
CN100350917C (zh) 2007-11-28
JP4291513B2 (ja) 2009-07-08
EP1889547A2 (de) 2008-02-20
ES2300140T3 (es) 2008-06-01
DE69937882T2 (de) 2009-01-02
US20120283185A1 (en) 2012-11-08
NZ338023A (en) 2001-10-26
AUPP327198A0 (en) 1998-05-21
EP1073444A4 (de) 2002-09-11
DE69937882D1 (de) 2008-02-14
CA2331071C (en) 2011-03-29
JP2002513544A (ja) 2002-05-14
WO1999056758A1 (en) 1999-11-11
EP1073444B1 (de) 2008-01-02
PL343831A1 (en) 2001-09-10
HK1033094A1 (en) 2001-08-17
CA2331071A1 (en) 1999-11-11
CN1307478A (zh) 2001-08-08

Similar Documents

Publication Publication Date Title
ATE382359T1 (de) Nahrungsmittelzusammensetzung und verfahren zu ihrer verwendung
ATE201134T1 (de) Verfahren zur herstellung von seiteneinsatzstücken für wegwerfartikel
DE69725169D1 (de) Zusammensetzungen und verfahren zur anregung des wachstums von neuriten
DE50210230D1 (de) Werkzeug zur Feinstbearbeitung von Oberflächen
DE69939070D1 (de) Verfahren zur quantifizierung von menschlicher wachsamkeit
DE69707849D1 (de) Verfahren zur reinigung von 1,4-butandiol
DE3860919D1 (de) Verbesserte detergens-bleichmittelzusammensetzung und verfahren zur reinigung von geweben.
DE69404455T2 (de) Entschwefelungsverfahren zur verbesserung der oxydationsbeständigkeit von werkstücken aus superlegierung
DE69715234T2 (de) Verfahren zur reinigung von 1,1-difluorethan
ATE127853T1 (de) Verfahren zur bestimmung der funktionellen wirkung von freiem protein s oder protein c in einer plasmaprobe.
DE69422812T2 (de) Verfahren zur herstellung von 1,1,1,3,3-pentafluorpropan und/oder 1,1,3,3,3-pentafluorpropen
DE59006757D1 (de) Knochennagel und Werkzeug für denselben.
DE69710078D1 (de) Verfahren zur reinigung von 1,1,1,3,3-pentafluorpropan
DE69704328T2 (de) Verfahren zur quantitativen Bestimmung von 1,5-Anhydroglucitol, sowie Reagenz zur quantitativen Bestimmung
DE69625581D1 (de) Cyanidfreies Reagenz und Verfahren zur Bestimmung von Hämoglobin und Leukozytendifferenzierung
DE59507509D1 (de) Verfahren zur Herstellung von N,N'-Carbonyldiazolen, insbesondere N,N'-Carbonyldiimidazol
DE3778158D1 (de) Inhibitoren von esterase produzierenden mikroorganismen zur hauptverwendung in deodorants.
DE383643T1 (de) Verfahren zur regelung des freien restchlorgehaltes.
DE68913995D1 (de) Zusammensetzung zur behandlung progressiver myopie.
IT1284097B1 (it) Processo in sospensione per la preparazione di copolimeri elastomerici dell'etilene
DE69002134D1 (de) Verfahren zur herstellung von 1,1-dichlor-1-fluoroethan und 1-chlor-1-1-difluorethan.
DE69114896T2 (de) Anordnung und Verfahren zur Voraussage des Wertes von gemischten Blutparametern.
ATA124192A (de) Verfahren zur bestimmung, quantifizierung und/oder ojektivierung von geruchsimmissionen, anordnung zur durchführung des verfahrens und verwendung desselben
DE59702788D1 (de) Verfahren zur herstellung von 4,6-diamino-resorcin-dihydrochlorid
DE69902115D1 (de) Verfahren zur Reinigung von 2-Amino-6-chlor-9-[(1'S,2'R)-1',2'-bis(hydroxymethyl)cyclopropan-1'-yl]methylpurin

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties